id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-1445-0065,FDA,FDA-2013-D-1445,"Blood Glucose Monitoring Test Systems for Prescription Point-of-Care
Use; Draft Guidance for Industry and Food and Drug Administration Staff;
Availability",Notice,Notice of Availability,2018-11-30T05:00:00Z,2018,11,2018-11-30T05:00:00Z,2019-03-01T04:59:59Z,2024-11-12T22:50:38Z,2018-26034,1,0,0900006483916275
FDA-2013-D-1445-0066,FDA,FDA-2013-D-1445,Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use Draft Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2018-11-30T05:00:00Z,2018,11,2018-11-30T05:00:00Z,,2024-11-12T22:49:53Z,,1,0,09000064839196ea